Wird geladen...
Mesenchymal stem cell therapy in type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic strategies. Transplantation of insulin-producing cells (IPCs) was once thought to be the most promising strategy for treating...
Gespeichert in:
| Veröffentlicht in: | Diabetol Metab Syndr |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433043/ https://ncbi.nlm.nih.gov/pubmed/28515792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-017-0233-1 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|